Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionTadalafil 5mg
Igtad-MD 5 Tablet
You Searched
Igtad-MD 5 Tablet
Ignyx Pharmaceuticals
₹200
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Erectile dysfunction
Customers also bought
More About Igtad
Benefits
In Treatment of Erectile dysfunction Igtad-MD 5 Tablet belongs to a group of medicines called PDE5 inhibitors. It works by relaxing the blood vessels in your penis. This allows blood to flow into the penis and produce an erection when sexually aroused. This medicine will only help get an erection if you are sexually stimulated. It is very effective but needs to be taken at least 30 minutes before sexual activity. Do not take this medicine if you also take medicines called nitrates (often given for chest pain).
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Do not handle the tablets with wet hands. Put it in your mouth but do not swallow it. Igtad-MD 5 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Igtad-MD 5 Tablet is a phosphodiesterase (PDE-5) inhibitor. It works in erectile dysfunction by increasing blood flow to penis by relaxing the muscles in penile blood vessels.
Unsafe: Avoid consuming alcohol with Igtad-MD 5 Tablet as it is deemed unsafe.
Safe when prescribed by an expert: Igtad-MD 5 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Seek medical advice from your doctor: Information regarding the use of Igtad-MD 5 Tablet during breastfeeding is not available. Doctor consultation is advised. Igtad-MD 5 Tablet is not indicated for use in women.
Not Safe: Igtad-MD 5 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Igtad-MD 5 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Igtad-MD 5 Tablet may be needed. Doctor consultation is advised.
Caution Advised: Igtad-MD 5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Igtad-MD 5 Tablet may be needed. Doctor consultation is advised. Use of Igtad-MD 5 Tablet is not recommended in patients with severe liver disease.
Manufacturer Address
10, Chiranjivi Complex,10/A,Uma C.H.S,Near Jain Merchant Society,Paldi,Ahmedabad
References
Michel T, Hoffman BB. Treatment of Myocardial Ischemia and Hypertension. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 752-53
Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 197
Tadalafil. Basingstoke, Hampshire: Eli Lilly and Company Limited; 2002 (04 Apr. 2019)
Tadalafil. Indianapolis, Indiana: Eli Lilly and Company; 2007 (04 Apr. 2019)
Coward RM, Carson CC. Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag. 2008 Dec;4(6):1315-30 (12 Jul. 2024)
Frajese GV, Pozzi F, Frajese G. Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence. Clin Interv Aging. 2006;1(4):439-49 (12 Jul. 2024)
Motawi AT, GamalEl Din SF, Meatmed EM, et al. Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study. Int Urol Nephrol. 2024 Mar 4 (12 Jul. 2024)
Ma J, Liu Z, Wu J, et al. Role of application of tadalafil 5 mg once-daily (?6 months) in men with erectile dysfunction from six randomized controlled trials. Transl Androl Urol. 2020 Jun;9(3):1405-1414 (12 Jul. 2024)
Shamohammadi I, Kazemeyni S, Sadighi M, et al. Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial. Asian J Urol. 2022 Aug 13;11(1):128-33 (12 Jul. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.